J. Hastedt

Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

Claus-Michael Lehr, William Doub, Per Bäckman, 2016 .

New directions in pharmaceutical amorphous materials and amorphous solid dispersions, a tribute to Professor George Zografi – Proceedings of the June 2016 Land O’Lakes Conference

M. Yazdanian, J. Hastedt, A. Newman, 2017, AAPS Open.

iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes

B. Forbes, C. Ehrhardt, A. Hickey, 2022, Molecular pharmaceutics.

iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System

B. Forbes, C. Ehrhardt, A. Hickey, 2022, Molecular pharmaceutics.

Erratum to: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

W. Doub, M. Sakagami, C. Lehr, 2016 .

A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.

A. Healy, I. Gitlin, J. Fahy, 2019, International journal of pharmaceutics.

Protein formulation and delivery

E. McNally, J. Hastedt, 2008 .

Diffusion in Porous Materials Above the Percolation Threshold

James L. Wright, J. Hastedt, 1990, Pharmaceutical Research.

The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes.

I. Gitlin, J. Fahy, R. Lundy, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Erratum to: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

W. Doub, M. Sakagami, C. Lehr, 2016 .